🇺🇸 FDA
Pipeline program

TH-SC01(Umbilical cord mesenchymal stem cells)

TH-SC01-RP-IIT-03

Phase 1 mab active

Quick answer

TH-SC01(Umbilical cord mesenchymal stem cells) for Rectal Injury is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Rectal Injury
Phase
Phase 1
Modality
mab
Status
active

Clinical trials